Exercise-Induced Endocannabinoids
Endogenous cannabinoid signaling during aerobic exercise and the biology of runner's high.
Your body makes endocannabinoids (mainly anandamide) during sustained aerobic exercise. This is real neurobiology, not marketing. The 'runner's high' genuinely tracks these molecules better than endorphins do. But this article shouldn't be called a terpene piece—endocannabinoids are signaling lipids your body synthesizes, not plant aromatics. Most downstream claims (dopamine effects, receptor mechanisms) still rest on rodent studies.
What exercise-induced endocannabinoids actually are
Endocannabinoids are lipid-derived signaling molecules synthesized by your body on demand from membrane phospholipids [1][2]. The two best-characterized are anandamide (AEA) and 2-arachidonoylglycerol (2-AG), both of which bind the cannabinoid receptors CB1 and CB2 — the same receptors targeted by THC [1][2]. Unlike classical neurotransmitters stored in vesicles, endocannabinoids are made when and where they are needed, then broken down within minutes by the enzymes FAAH (for AEA) and MAGL (for 2-AG) [1]. Strong evidence
Critical clarification: Endocannabinoids are not terpenes. Terpenes are volatile plant aromatics like myrcene or limonene. Endocannabinoids are endogenous human signaling lipids. The two systems interact pharmacologically — plant cannabinoids hit the same receptors — but they are different chemical classes.
Exercise-induced elevation of endocannabinoids
In 2003, Sparling and colleagues demonstrated that 50 minutes of running or cycling at moderate intensity significantly elevated plasma anandamide in healthy young men [3]. That finding has been replicated and extended: a 2012 study by Raichlen et al. found that AEA rises with running and may be tuned to species that evolved for endurance locomotion [4]. A 2004 review by Dietrich and McDaniel summarized the human evidence: AEA reliably increases after aerobic exercise of sufficient intensity and duration, typically in the moderate-to-vigorous range (~70–85% of maximum heart rate) [5]. Strong evidence
2-AG findings in humans are less consistent across studies, and most of what we know about its exercise response comes from rodent work [5]. Weak / limited
The runner's high: endocannabinoids vs. endorphins
The 'runner's high' was attributed to endorphins for decades, largely on the basis of correlation: endorphins rise during exercise. But endorphins are large peptides that don't readily cross the blood–brain barrier, which made the mechanistic story problematic [6].
The cleanest test came in 2021. Siebers et al. conducted a double-blind, placebo-controlled trial in which runners received either naloxone (an opioid blocker) or a CB1/CB2 cannabinoid receptor blocker before exercise. Blocking opioids did not abolish the post-run euphoria and reduced anxiety. The pattern was consistent with endocannabinoids — not endorphins — driving the subjective runner's high [6]. Strong evidence
This does not mean opioids play no role in exercise-related analgesia or reward; it means the specific euphoric, anxiolytic feeling after a sustained run tracks the endocannabinoid system more closely than the endorphin system.
Documented and reported effects
Well-supported effects of exercise-driven endocannabinoid elevation:
- Reduced anxiety and improved mood after the workout [5][6]. Strong evidence
- Exercise-induced hypoalgesia (reduced pain sensitivity), at least partly cannabinoid-mediated [5]. Weak / limited
- Mild sedation or calm lasting tens of minutes to a couple of hours post-exercise [5]. Weak / limited
Not well supported:
- That endocannabinoids from exercise produce euphoria comparable to inhaled THC. The subjective effects are real but modest, and direct comparison is lacking. Disputed
- That you can 'stack' a workout with cannabis use to amplify effects in any predictable way. This is gym folklore; controlled human data are essentially absent. No data
- That specific supplements or foods reliably boost exercise-induced AEA in humans. No data
- That CB1 signaling, FAAH inhibition, and downstream dopamine cascade during exercise are fully characterized in humans. Most mechanistic claims come from rodent studies and should not be read as settled human pharmacology [1][5]. Weak / limited
Interaction with exogenous cannabis use
Because plant cannabinoids like THC act on the same CB1 receptors that endocannabinoids do, there is interest in whether using cannabis before or after exercise changes the experience. The honest answer is: controlled human data are essentially absent. Observational surveys in legal-cannabis jurisdictions suggest some users report enjoying workouts more with cannabis, but self-report in unblinded users is a weak design and subject to expectancy bias [7]. Weak / limited
Chronic heavy cannabis use down-regulates CB1 receptors, which could in principle blunt the exercise endocannabinoid response — but this is mechanistically plausible, not demonstrated in human exercise trials. No data
Why this is not a terpene article
This article is filed under endocannabinoid biology, not terpene chemistry. For clarity:
- Aroma: Endocannabinoids are non-volatile signaling lipids; they have no aroma.
- Where it's found in plants: AEA and 2-AG are synthesized in mammalian tissue, not in cannabis. (Trace N-acylethanolamines exist in some plants, but are not 'aromatics' or terpenes.)
- Strains dominant in this terpene: No cannabis strain contains anandamide or 2-AG.
- Related terpenes: Not applicable. Related molecules are other endocannabinoids (e.g., 2-AG, noladin ether) and plant cannabinoids that bind the same receptors.
If you came here looking for actual cannabis terpenes, try Myrcene, Gamma-Selinene, or Terpinen-4-ol.
Sources
- Peer-reviewed Lu HC, Mackie K. An introduction to the endogenous cannabinoid system. Biological Psychiatry. 2016;79(7):516-525.
- Peer-reviewed Di Marzo V. New approaches and challenges to targeting the endocannabinoid system. Nature Reviews Drug Discovery. 2018;17(9):623-639.
- Peer-reviewed Sparling PB, Giuffrida A, Piomelli D, Rosskopf L, Dietrich A. Exercise activates the endocannabinoid system. NeuroReport. 2003;14(17):2209-2211.
- Peer-reviewed Raichlen DA, Foster AD, Gerdeman GL, Seillier A, Giuffrida A. Wired to run: exercise-induced endocannabinoid signaling in humans and cursorial mammals with implications for the 'runner's high.' Journal of Experimental Biology. 2012;215(8):1331-1336.
- Peer-reviewed Dietrich A, McDaniel WF. Endocannabinoids and exercise. British Journal of Sports Medicine. 2004;38(5):536-541.
- Peer-reviewed Siebers M, Biedermann SV, Bindila L, Lutz B, Fuss J. Exercise-induced euphoria and anxiolysis do not depend on endogenous opioids in humans. Psychoneuroendocrinology. 2021;126:105173.
- Peer-reviewed YorkWilliams SL, Gust CJ, Mueller R, et al. The new runner's high? Examining relationships between cannabis use and exercise behavior in states with legalized cannabis. Frontiers in Public Health. 2019;7:99.
How this page was made
Generation history
Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.
Related
- Cannabis-Induced Anxiety — How THC dose, individual vulnerability, and setting trigger acute anxiety; what actually h...
- Runner's High and Endocannabinoids — How the body's own cannabinoid system drives the mood and pain relief of aerobic exercise.